I. Proscurshim

发表

Upper Gastrointestinal Hemorrhage: Diagnosis and Treatment

J. Gama-Rodrigues, C. Jacob, I. Proscurshim, 2010 .

Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey

R. Perez, A. Habr-Gama, S. Nahas, 2011, Techniques in Coloproctology.

Lymph Node Size in Rectal Cancer Following Neoadjuvant Chemoradiation—Can We Rely on Radiologic Nodal Staging After Chemoradiation?

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2009, Diseases of the colon and rectum.

Nonoperative approaches to rectal cancer: a critical evaluation.

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2011, Seminars in radiation oncology.

Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Total mesorectal excision and sphincter preservation - the early steps of rectal cancer surgery

R. Perez, C. Sabbagh, I. Proscurshim, 2014 .

Clinical relevance of positron emission tomography/computed tomography‐positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation

C. Buchpiguel, R. Perez, A. Habr-Gama, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Clinical Investigation : Gastrointestinal Cancer Optimal Timing for Assessment of Tumor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer : Do All Patients Benefit From Waiting Longer Than 6 Weeks ?

C. Buchpiguel, J. Gama-Rodrigues, R. Perez, 2022 .

Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2008, International journal of radiation oncology, biology, physics.

The need for effective radiosentitizing agents: experience in patients with complete pathological response

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2011, Anti-cancer drugs.

Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2006, Journal of Gastrointestinal Surgery.

Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen

C. Buchpiguel, J. Gama-Rodrigues, R. Perez, 2016, Radiation Oncology.

Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2014, Journal of surgical oncology.

Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging

C. Buchpiguel, R. Perez, A. Habr-Gama, 2014, Techniques in Coloproctology.

Transanal Endoscopic Microsurgery for Residual Rectal Cancer (ypT0-2) Following Neoadjuvant Chemoradiation Therapy: Another Word of Caution

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2013, Diseases of the colon and rectum.

Transanal Endoscopic Microsurgery for Residual Rectal Cancer After Neoadjuvant Chemoradiation Therapy Is Associated With Significant Immediate Pain and Hospital Readmission Rates

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2011, Diseases of the colon and rectum.

Chemoradiation Therapy: Nonoperative Approaches

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2010 .

Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer.

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2010, Surgical oncology clinics of North America.

The Role of Carcinoembriogenic Antigen in Predicting Response and Survival to Neoadjuvant Chemoradiotherapy for Distal Rectal Cancer

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2009, Diseases of the colon and rectum.

Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2016, Annals of Surgical Oncology.

Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2014, International journal of radiation oncology, biology, physics.

Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation

C. Buchpiguel, J. Gama-Rodrigues, R. Perez, 2012, Cancer.

Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation

J. Jorge, J. Gama-Rodrigues, R. Perez, 2016, Diseases of the colon and rectum.

Management of adenomas within the area of rectal cancer that develop complete pathological response

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2015, International Journal of Colorectal Disease.

Loop Ileostomy Morbidity: Timing of Closure Matters

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2006, Diseases of the colon and rectum.

Endoscopic management of postoperative stapled colorectal anastomosis hemorrhage

R. Perez, A. Habr-Gama, I. Proscurshim, 2007, Techniques in Coloproctology.

Absence of Lymph Nodes in the Resected Specimen After Radical Surgery for Distal Rectal Cancer and Neoadjuvant Chemoradiation Therapy: What does it Mean?

R. Perez, A. Habr-Gama, I. Cecconello, 2008, Diseases of the colon and rectum.

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma

F. Bosch, L. Gordon, J. Radford, 2020, Clinical Cancer Research.

Laparoscopic versus standard appendectomy outcomes and cost comparisons in the private sector

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2005, Journal of Gastrointestinal Surgery.

Peritumoral Inflammatory Infiltrate is not a Prognostic Factor in Distal Rectal Cancer Following Neoadjuvant Chemoradiation Therapy

R. Perez, A. Habr-Gama, I. Cecconello, 2007, Journal of Gastrointestinal Surgery.

Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2008, International Journal of Colorectal Disease.

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)

F. Bosch, L. Gordon, J. Radford, 2023, Oncotarget.

Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer: Are We Getting Closer to Anal Cancer Management?

Angelita Habr-Gama, Jorge Sabbaga, J. Gama-Rodrigues, 2013, Diseases of the colon and rectum.

Distribution of lymph nodes in the mesorectum: how deep is TME necessary?

R. Perez, A. Habr-Gama, I. Proscurshim, 2008, Techniques in Coloproctology.

Transanal Local Excision for Distal Rectal Cancer and Incomplete Response to Neoadjuvant Chemoradiation – Does Baseline Staging Matter?

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2014, Diseases of the colon and rectum.

Local Excision for ypT2 Rectal Cancer—Much Ado About Something

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2007, Journal of Gastrointestinal Surgery.

Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen

C. Buchpiguel, J. Gama-Rodrigues, R. Perez, 2016, Radiation oncology.

Phase 1/2 open-label, multiple ascending dose trial of AGEN2034, an anti-PD-1 monoclonal antibody, in advanced solid malignancies: Results of dose escalation.

H. Youssoufian, O. Shebanova, Joyce F. Liu, 2018 .

476 First-in-human phase 1/2 study of the first-in-class SUMO-activating enzyme inhibitor TAK-981 in patients with advanced or metastatic solid tumors or relapsed/refractory lymphoma: phase 1 results

D. Juric, A. Berger, A. Dowlati, 2021, Journal for ImmunoTherapy of Cancer.

Transanal Endoscopic Microsurgery for Residual Rectal Cancer (ypT0-2) Following Neoadjuvant Chemoradiation Therapy: Another Word of Caution

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2013, Diseases of the colon and rectum.

Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?

J. Gama-Rodrigues, R. Perez, A. Habr-Gama, 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Absence of Lymph Nodes in the Resected Specimen After Radical Surgery for Distal Rectal Cancer and Neoadjuvant Chemoradiation Therapy: What does it Mean?

R. Perez, A. Habr-Gama, I. Cecconello, 2008, Diseases of the colon and rectum.

The Sumoylation Inhibitor TAK-981 in Combination with the CD19-Targeting Antibody Tafasitamab Shows Enhanced Anti-Tumor Activity in Preclinical B-Cell Lymphoma Models

A. Berger, Keli Song, A. Nakamura, 2021, Blood.

TAK-981, a First-in-Class SUMO-Activating Enzyme Inhibitor, Combined with Rituximab in Adult Patients (Pts) with CD20-Positive Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Phase 1 Data

A. Berger, T. Phillips, L. Alinari, 2021, Blood.